BioSpace News Archive

Business

NodThera Secures $55 Million to Develop NLRP3 Inflammasome Inhibitors

U.K.-based NodThera is building up its war chest to develop therapies for diseases driven by chronic inflammation.

June 3, 2020
·
2 min read
·
Alex Keown
Drug Development

Imago BioSciences Advances Myelofibrosis Trials, With Phase IIb Prelim Readout Imminent

Imago BioSciences will announce preliminary results from its Phase IIb clinical trial for myelofibrosis (MF) at the 25th European Hematology Association (EHA) Annual Congress that begins June 12, 2020.

June 3, 2020
·
3 min read
·
Gail Dutton
Antimicrobial Ingredients Market: High Demand for Antibacterial Agents to Drive Market Growth through 2026

The antimicrobial ingredients market is expected to register robust growth. The growing safety concerns are expected to drive demand of antimicrobial ingredient laden products into new sectors.

June 3, 2020
·
4 min read
Anatomic Pathology Market: Instruments Products & Services Segment to Emerge Attractive in Forthcoming Years

The anatomic pathology market worldwide is experiencing stiff competition because of the presence of numerous large companies and a handful of regional players challenging their might in the local pockets.

June 3, 2020
·
4 min read
Angiography Devices Market: Coronary Angiography Devices Hold Prominent Position

The global market for angiography devices is highly competitive in nature with a large number of players operating in it across the globe, states a new research report published by Transparency Market Research.

June 3, 2020
·
4 min read
Business

Sectra’s Year-end Report 2019/2020: Sectra Grows With Increased Profitability-operating Profit for the Year Increased 25.4%

International medical imaging IT and cybersecurity company Sectra reports the best earnings year in its history, exceeding its three financial goals.

June 3, 2020
·
5 min read
Policy

New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis

TGA has granted provisional designation for new drug Lurbinectedin based on encouraging Phase 2 results and high unmet medical need

June 3, 2020
·
7 min read
Isofol’s Rights Issue Oversubscribed

Isofol Medical AB fully guaranteed new share issue with preferential rights for the Company’s existing shareholders, which ended on June 1, 2020, was oversubscribed.

June 3, 2020
·
8 min read
Deals

Shorla Pharma Closes $8.3M Series A Funding Round - June 03, 2020

Shorla Pharma Limited, an Irish specialty pharmaceutical company, has announced the completion of a Series A investment of $8.3 million.

June 3, 2020
·
4 min read
New publication shows Smith+Nephew’s OXINIUM™ (Oxidized Zirconium) on XLPE for total hip arthroplasty as best performing bearing beyond 10 years

Smith+Nephew, the global medical technology business, announced the publication of new clinical evidence further validating the exceptional performance of its proprietary OXINIUM - Oxidized Zirconium - on XLPE for total hip arthroplasty.

June 3, 2020
·
6 min read